Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$12,801 Mln
Revenue (TTM)
$19,628 Mln
Net Profit (TTM)
$651 Mln
ROE
0.1 %
ROCE
-- %
P/E Ratio
11.4
P/B Ratio
0.8
Industry P/E
--
EV/EBITDA
5.7
Div. Yield
3.7 %
Debt to Equity
0.8
Book Value
$25
EPS
$1.7
Face value
--
Shares outstanding
558,577,770
CFO
€23,696.74 Mln
EBITDA
€26,482.27 Mln
Net Profit
€10,750.53 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Fresenius Medical Care AG - ADR
| -6.2 | -4.8 | -6.2 | -10.3 | 1.7 | -9.5 | -6.6 |
|
BSE Sensex*
| -13.7 | -10.1 | -14.2 | -3.8 | 7.4 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Fresenius Medical Care AG - ADR
| 5.2 | 8.6 | 27.5 | -49.7 | -21.9 | 12.8 | 13.7 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Fresenius Medical Care AG - ADR
|
22.3 | 12,800.6 | 19,628.0 | 978.0 | 9.1 | 6.8 | 11.4 | 0.8 |
| 6.3 | 913.1 | 174.7 | -115.2 | 0.0 | -80.2 | -- | 7.4 |
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a... network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Address: Else-Kröner-Strasse 1, Bad Homburg, Germany, 61352 Read more
CEO & Chair of Management Board of Fresenius Med. Care Mgmt AG
Ms. Helen Giza
Chair of Management Board & CEO
Ms. Helen Giza
Headquarters
Bad Homburg
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Fresenius Medical Care AG - ADR is $22.34 (NYSE) as of 01-Apr-2026 16:00 EDT. Fresenius Medical Care AG - ADR has given a return of 1.67% in the last 3 years.
The P/E ratio of Fresenius Medical Care AG - ADR is 11.45 times as on 31-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
13.93
|
0.95
|
|
2024
|
49.40
|
1.82
|
|
2023
|
36.73
|
1.35
|
|
2022
|
28.45
|
1.37
|
|
2021
|
29.71
|
2.06
|
The 52-week high and low of Fresenius Medical Care AG - ADR are Rs 30.46 and Rs 21.02 as of 02-Apr-2026.
Fresenius Medical Care AG - ADR has a market capitalisation of $ 12,801 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Fresenius Medical Care AG - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-0.22
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.